Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × trametinib × 1 year × Clear all

Sponsor

Conditions

Melanoma 22 Carcinoma, Non-Small-Cell Lung 12 Multiple Myeloma 8 Colorectal Neoplasms 8 Neoplasm Metastasis 7 Glioma 7 Thyroid Neoplasms 6 Thyroid Carcinoma, Anaplastic 5 Hematologic Neoplasms 5 Lymphoma 4 Pancreatic Neoplasms 3 Neoplasms 3 Lung Neoplasms 3 Astrocytoma 3 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Recurrence 2 Neurofibromatosis 1 2 Histiocytosis, Langerhans-Cell 2 Glioblastoma 2 Fever 2 Brain Neoplasms 2 Uveal Melanoma 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Solid Tumors, KRAS Mutation; SOS1 1 Solid Tumor Cancer 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Rectal Neoplasms 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡